Advances in DNA and mRNA-Based strategies for Cancer Immunotherapy: Part B
AvKennet Murphy,Kenneth Murphy
Del 166 i serien Advances in Immunology
2 149 kr
Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.
Beskrivning
- Presents current developments and comprehensive reviews in immunology
- Provides the latest in a longstanding and respected serial on the subject matter
- Focuses on recent advances in the field of immunology
Produktinformation
- Utgivningsdatum:2025-08-15
- Mått:152 x 229 x undefined mm
- Vikt:450 g
- Format:Inbunden
- Språk:Engelska
- Serie:Advances in Immunology
- Antal sidor:272
- Förlag:Elsevier Science
- ISBN:9780443317484
Mer om författaren
Kenneth M. Murphy works in Washington University School of Medecine, USA. Frederick W. Alt is a Howard Hughes Medical Institute (HHMI) Investigator and Director of the Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital (BCH). He is the Charles A. Janeway Professor of Pediatrics and Professor of Genetics at Harvard Medical School. He works on elucidating mechanisms that generate antigen receptor diversity and, more generally, on mechanisms that generate and suppress genomic instability in mammalian cells, with a focus on the immune and nervous systems. Recently, his group has developed senstive genome-wide approaches to identify mechanisms of DNA breaks and rearrangements in normal and cancer cells. He has been elected to the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the European Molecular Biology Organization. His awards include the Albert Szent-Gyorgyi Prize for Progress in Cancer Research, the Novartis Prize for Basic Immunology, the Lewis S. Rosensteil Prize for Distinugished work in Biomedical Sciences, the Paul Berg and Arthur Kornberg Lifetime Achievement Award in Biomedical Sciences, and the William Silan Lifetime Achievement Award in Mentoring from Harvard Medical School. Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at Vivekanand Global University, India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies. Dr. Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Gwalior. He has extensive teaching and research experience in pharmaceutics, with particular expertise in novel drug delivery systems, localized and targeted drug delivery, and nanocarrier-based therapeutics for cancer and neurodegenerative disorders. His research interests focus on advanced pharmaceutical formulations and controlled delivery approaches aimed at improving therapeutic outcomes.Dr. Mishra has supervised postgraduate and doctoral research scholars and has contributed widely to academic literature through research publications, books, and book chapters with leading international publishers. He is also associated with innovation in pharmaceutical sciences through patented research contributions. Over the course of his career, he has received several academic and scientific recognitions for his contributions to teaching, research, and pharmaceutical education. He has additionally been recognized internationally for his research impact and scholarly contributions in the field of pharmaceutical sciences.Sumel Ashique has been working as an assistant professor at Bengal College of Pharmaceutical Sciences & Research, Durgapur West Bengal, India, West Bengal, India. He has several years of teaching experience. He has achieved 70+ publications of International and national accredited reputed journals . He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He has also 6 granted patents from IP and Australia & dozens of book chapters have been submitted to well-known publishers. Dr. Pranav Kumar Prabhakar is currently working as a Professor and Head at Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India. He is among the World’s Top 2% Scientists (list published by Stanford University, USA, 2021, 2022, 2023, 2024, and 2025). He completed his PhD in Biotechnology from IIT Madras. His research focuses on elucidating molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders (diabetes) using natural products. Dr. Pranav is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. He serves as an editorial board member and reviewer for many reputed national and international journals. His honors include a travel grant from IIT Madras and the Council for Scientific and Industrial Research (CSIR) to attend ATTD 2009 in Greece, approved by the Department of Science and Technology (DST). He has published over 160+ research articles, authored/edited 24 books, and 48 book chapters, and delivered 9 oral and poster presentations at scientific meetings.
Innehållsförteckning
- 1. Harnessing the immune system: Insights into cancer vaccines Sushree Subhadra Acharya, Subhasmita Bhal, Biswajit Das, and Chanakya Nath Kundu 2. Lipid nanoparticle mediated mRNA delivery in cancer immunotherapy Gyati Shilakari Asthana, Saptarshee Bhattacharjee, Jitendra Kumar, Soyal Sayyed, Amulya Jindal, Pankaj Kumar, Abhijeet Chinchane, Atreyee Bhattacharyya, Roshani Jaiswal, Sagar Kulkarni, Shubham Gajdhane, Jitender Madan, and Abhay Asthana 3. Nanoparticles for mRNA-based cancer immunotherapy Rakesh Pahwa, Gulshan Sharma, Rohil Panwar, and Neeraj Mishra 4. B-cell editing: An emerging alternative of precision oncotherapy Pritha Roy Choudhury, Mohona Chakravarti, Saptak Banerjee, Rathindranath Baral, and Anamika Bose 5. Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapy Krishnendu Adhikary, Abhik Paul, Ayush Madan, Anas Islam, Sumel Ashique, and Mohhammad Ramzan 6. Revolutionizing cancer treatment: Exploring novel immunotherapeutics, checkpoints, bispecifics, and vaccines in development Anas Islam, Vijay Singh, Pooja S. Murkute, Sumel Ashique, Shriyansh Srivastava, Mohammad Yousuf Ansari, and Sabina Yasmin 7. Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA & mRNA vaccine in cancer immunotherapy Monika Kaushik, Prathap Madeswaraguptha, Murugesan Vanangamudi, Vijayaraj Surendran, Sumel Ashique, Anas Islam, Naheed Mojgani, and Afzal Hussain
Du kanske också är intresserad av
- Nyhet